Squarepoint Ops LLC Trevi Therapeutics, Inc. Transaction History
Squarepoint Ops LLC
- $57 Billion
- Q1 2024
A detailed history of Squarepoint Ops LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 15,027 shares of TRVI stock, worth $38,769. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,027
Previous 99,491
84.9%
Holding current value
$38,769
Previous $133,000
61.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TRVI
# of Institutions
79Shares Held
50.5MCall Options Held
2.2KPut Options Held
600-
Nea Management Company, LLC Timonium, MD11.4MShares$29.3 Million2.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$19 Million1.34% of portfolio
-
Rubric Capital Management LP New York, NY5.56MShares$14.4 Million0.65% of portfolio
-
Viking Global Investors LP4.4MShares$11.4 Million0.06% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$8.83 Million1.01% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $150M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...